Choroidal melanoma: Natural history and management options

Cancer Control

Volumn 11, Issue 5, 2004, Pages 296-303

  Bell, Darren J ^a   Wilson, Matthew W ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60; IODINE 125; IRIDIUM 192; PALLADIUM 103; RUTHENIUM 106; STRONTIUM 90;

BEAM THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL VIABILITY; CENTRAL RETINA VEIN OCCLUSION; CHOROID MELANOMA; CLINICAL TRIAL; ENUCLEATION; EPIPHORA; GLAUCOMA; HIGH TEMPERATURE; HUMAN; IONIZING RADIATION; MELANOMA CELL; METASTASIS; MICROWAVE RADIATION; NECROSIS; NEOVASCULAR GLAUCOMA; NONHUMAN; OPTIC NERVE ATROPHY; RADIATION CATARACT; RADIATION DOSE; RADIATION INJURY; RETINA DETACHMENT; RETINA DISEASE; RETINA MACULA CYSTOID EDEMA; RETINA MACULOPATHY; RETINOPATHY; REVIEW; SCLERA DISEASE; SCLERECTOMY; STRABISMUS; TRANSPUPILLARY THERMOTHERAPY; TREATMENT FAILURE; TUMOR LOCALIZATION; TUMOR VOLUME; UVEA MELANOMA; VITREOUS HEMORRHAGE;

EID: 14644421465     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480401100503     Document Type: Review

References (67)

1. Seregard S. Posterior uveal melanoma: the Swedish perspective. Acta Ophthalmol Scand. 1996;74:315-329.
2. Wilkes SR, Robertson DM, Kurland LT, et al. Incidence of uveal malignant melanoma in the resident population of Rochester and Olmsted County, Minnesota. Am J Ophthalmol. 1979;87:639-641.
3. Wilkes S, Kurland L, Campbell RJ, et al. Incidence of uveal malignant melanoma. Am J Ophthalmol. 1979;88:629-630.
4. De Potter P, Shields CL, Shields JA. New treatment modalities for uveal melanoma. Curr Opin Ophthalmol. 1996;7:27-32.
5. Augsburger JJ. Is observation really appropriate for small choroidal melanomas? Trans Am Ophthalmol Soc. 1993;91:147-168.
6. Zimmerman LE, McLean IW, Foster WD. Statistical analysis of follow-up data concerning uveal melanomas, and the influence of enucleation. Ophthalmology. 1980;87:557-564.
7. Shields JA, Shields CL, Donoso LA. Management of posterior uveal melanoma. Surv Ophthalmol. 1991;36:161-195.
8. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report No. 10. Am J Ophthalmol. 1998;125:779-796.
9. Mooy CM, De Jong PT. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol. 1996;41:215-228.
10. McLean IW, Foster WD, Zimmerman LE, et al. Inferred natural history of uveal melanoma. Invest Ophthalmol Vis Sci. 1980;19:760-770.
11. Zakka KA, Foos RY, Omphroy CA, et al. Malignant melanoma: analysis of an autopsy population. Ophthalmology. 1980;87:549-556.
12. Kujala E, Makitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651-4659.
13. Kath R, Hayungs J, Bornfeld N, et al. Prognosis and treatment of disseminated uveal melanoma. Cancer. 1993;72:2219-2223.
14. Shields JA. Lesions simulating malignant melanoma of the posterior uvea. Arch Ophthalmol. 1973;89:466-471.
15. Chang M, Zimmerman LE, McLean I. The persisting pseudomelanoma problem. Arch Ophthalmol. 1984;102:726-727.
16. Collaborative Ocular Melanoma Study Group. Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report No. 1. Arch Ophthalmol. 1990;108:1268-1273. Erratum in: Arch Ophthalmol. 1990;108:1708.
17. Shields CL, Shields JA, Kiratli H, et al. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology. 1995;102:1351-1361.
18. Diener-West M, Hawkins BS, Markowitz JA, et al. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992;110:245-250.
19. Eskelin S, Pyrhonen S, Summanen P. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology. 2000;107:1443-1449.
20. Eskelin S, Kivelä T. Uveal melanoma: implications of tumor doubling time. Author's reply. Ophthalmology. 2001;108:830-831.
21. Shields CL, Cater J, Shields JA, et al. Combination of clinical factors predictive of growth of small choroidal melanocytic tumors. Arch Ophthalmol. 2000;118:360-364.
22. McLean IW. Discussion of "risk factors for growth and metastasis of small choroidal melanocytic lesions." Ophthalmology. 1995;102:1361.
23. Zimmerman LE, McLean IW. An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol. 1979;87:741-760.
24. Fraunfelder FT, Boozman FW, Wilson RS, et al. No-touch technique for intraocular malignant melanomas. Arch Ophthalmol. 1977;95:1616-1620.
25. Wilson RS, Fraunfelder FT. "No-touch" cryosurgical technique: a minimal trauma technique for eyes harboring intraocular malignancy. Ophthalmology. 1978;85:1170-1175.
26. McCubbin JA, Spratt JS. The value of no-touch isolation technique for the resection of cancer: the eye as a model. Arch Surg. 1980;115:224-228.
27. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled. COMS report No. 9. Am J Ophthalmol. 1998;125:767-778.
28. Moore RF. Choroidal sarcoma treated by intraocular insertion of radon seeds. Br J Ophthalmol. 1930;14:145-152
29. Journée-de Korver JG, Keunen JEE. Thermotherapy in the management of choroidal melanoma. Prog Retin Eye Res. 2002;21:303-317.
30. Shields CL, Cater J, Shields JA. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients. Arch Ophthalmol. 2002;120:933-940.
31. Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No 43. American Association of Physicists in Medicine. Med Phys. 1995;22:209-234.
32. The Collaborative Ocular Melanoma Study (COMS) randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS report No. 18. Arch Ophthalmol. 2001;119:969-982.
33. Puusaari I, Heikkonen J, Summanen P, et al. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Ophthalmology. 2003;110:2223-2234.
34. Wilson MW, Alejandro KC, Cantrell JE, et al. 125-I episcleral plaque brachytherapy in the management of large melanomas of the ciliary body and/or of the choroid. Scientific Poster 76, 2002. Presented at the Joint Meeting American Academy of Ophthalmology and Pan-American Association of Ophthalmology. Oct 20-23, 2002; Orlando, FL.
35. Wilson MW, Hungerford JL. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology. 1999;106:1579-1587.
36. Karlsson UL, Augsburger JJ, Shields JA, et al. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy. Ophthalmology. 1989;96:382-388.
37. Lommatzsch PK, Kirsch IH. 106Ru/106Rh plaque radiotherapy for malignant melanomas of the choroid: with follow-up results more than 5 years. Doc Ophthalmol. 1988;68:225-238.
38. Gunduz K, Shields CL, Shields JA, et al. Radiation retinopathy following plaque radiotherapy of posterior uveal melanoma. Arch Ophthalmol. 1999;117:609-614.
39. CharDH, Castro JR, Quivey JM, et al. Uveal melanoma radiation: 125I brachytherapy versus helium ion irradiation. Ophthalmology. 1989;96:1708-1715.
40. Gragoudas ES, Goitein M, Verhey L, et al. Proton beam irradiation: an alternative to enucleation for intraocular melanomas. Ophthalmology. 1980;87:571-581.
41. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthal. 1997;42:215-232.
42. Gragoudas ES, Lane AM, Regan S, et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000;118:773-778.
43. Li W, Gragoudas ES, Egan KM. Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma. Arch Ophthalmol. 2003;121:68-72.
44. Foulds WS, Damato BE. Alternatives to enucleation in the management of choroidal melanoma. Aust N Z J Ophthalmol. 1986;14:19-27.
45. Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report No. 6. Am J Ophthalmol. 1998;125:745-766.
46. Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology. 2004;111:977-983.
47. Finger PT, Packer S, Paglione RW, et al. Thermoradiotherapy of choroidal melanoma: clinical experience. Ophthalmology. 1989;96:1384-1388.
48. Journée-de Korver JG, Oosterhuis JA, Van Best JA, et al. Xenon arch photocoagulator used for transpupillary hyperthermia. Doc Ophthalmol. 1991;78:183-187.
49. Journée-de Korver JG, Oosterhuis JA, Kakebeeke-Kemme HM. Transpupillary thermotherapy (TTT) by infrared irradiation of choroidal melanoma. Doc Ophthalmol. 1992;82:185-191.
50. Oosterhuis JA, Journée-de Korver HG, Kakebeeke-Kemme HM, et al. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol. 1995;113:315-321.
51. Journée-de Korver JG, Verberg-van der Marel EH, Oosterhuis JA, et al. Tumoricidal effect of hyperthermia by near infrared irradiation on pigmented hamster melanoma. Lasers Light Ophthalmol. 1992;4:175-180.
52. Shields CL, Shields JA, Perez N, et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology. 2002;109:225-234.
53. Robertson DM, Salomão DR. The effect of transpupillary thermotherapy on the human macula. Arch Ophthalmol. 2002;120:652-656.
54. Robertson DM, Buettner H, Bennett SR. Transpupillary thermotherapy as primary treatment for small choroidal melanomas. Arch Ophthalmol. 1999;117:1512-1519.
55. Stoffelns BM. Primary transpupillary thermotherapy (TTT) for malignant choroidal melanoma. Acta Ophthalmol Scand. 2002;80:25-31.
56. Shields CL, Shields JA, Cater J, et al. Transpupillary thermotherapy for choroidal melanoma: tumor control and visual results in 100 consecutive cases. Ophthalmology. 1998;105:581-590.
57. Shields CL, Shields JA, De Potter P, et al. Transpupillary thermotherapy in the management of choroidal melanoma. Ophthalmology. 1996;103:1642-1650.
58. Egan KM, Ryan LM, Gragoudas ES. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates. Arch Ophthalmol. 1998;116:366-370.
59. Finger PT, Lipka AC, Lipkowitz JL, et al. Failure of transpupillary thermotherapy (TTT) for choroidal melanoma: two cases with histopathological correlation. Br J Ophthalmol. 2000;84:1075-1076.
60. Midena E, Pilotto E, de Belvis V, et al. Choroidal vascular changes after transpupillary thermotherapy for choroidal melanoma. Ophthalmology. 2003;110:2216-2222.
61. Harbour JW, Meredith TA, Thompson PA, et al. Transpupillary thermotherapy versus plaque radiotherapy for suspected choroidal melanomas. Ophthalmology. 2003;110:2207-2215.
62. Zaldivar RA, Aaberg TM, Sternberg P Jr, et al. Clinicopathologic findings in choroidal melanomas after failed transpupillary thermotherapy. Am J Ophthalmol. 2003;135:657-663.
63. Journée-de Korver JG, Oosterhuis JA, de Wolff-Rouendaal D, et al. Histopathological findings in human choroidal melanomas after transpupillary thermotherapy. Br J Ophthalmol. 1997;81:234-239.
64. Robertson DM, Campbell RJ, Weaver DT. Residual intrascleral and intraretinal melanoma: a concern with lamellar sclerouvectomy for uveal melanoma. Am J Ophthalmol. 1991;112:590-593.
65. Donders PC. Malignant melanoma of the choroid. Trans Ophthalmol Soc UK. 1973;93:745-751.
66. Oosterhuis JA, Journée-de Korver HG, Keunen JE. Transpupillary thermotherapy: results in 50 patients with choroidal melanoma. Arch Ophthalmol. 1998;116:157-162.
67. Robertson DM. TTT as rescue treatment for choroidal melanoma not controlled with iodine-125 brachytherapy. Ocul Immunol Inflamm. 2002;10:247-252.